British HIV Association guidelines for HIV-associated malignancies 2008.
Bower
M
M
Department of Oncology, Chelsea & Westminster Hospital, London, UK. m.bower@imperial.ac.uk
Collins
S
S
Cottrill
C
C
Cwynarski
K
K
Montoto
S
S
Nelson
M
M
Nwokolo
N
N
Powles
T
T
Stebbing
J
J
Wales
N
N
Webb
A
A
D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D016483:Lymphoma, AIDS-Related / Q000175:diagnosis / Q000628:therapy* / Q000821:virology; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D012017:Referral and Consultation; D012514:Sarcoma, Kaposi / Q000175:diagnosis / Q000628:therapy* / Q000821:virology; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000628:therapy* / Q000821:virology